EFDID: 504105EFD: View Filing

Issuer: OS Therapies Inc (0001795091) - D

Accession: 0001795091-23-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001795091
  • Entity Name:
    OS Therapies Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    15825 SHADY GROVE ROAD
    SUITE 135
    ROCKVILLE, MD 20850
  • Persons:
    Related Persons 7
    Paul A. Romness
    Executive Officer, Director 
    Founder, President, Chief Executive Officer and Director
    Robert G. Petit
    Executive Officer 
    Chief Medical Officer and Chief Scientific Officer
    Christopher P. Acevedo
    Executive Officer 
    Chief Financial Officer
    Colin Goddard
    Director 
    Chairman of the Board
    Joacim Borg
    Director
    John Ciccio
    Director
    Theodore F. Search
    Director
EDGAR: Offering Information
  • Accession Date:
    12/14/2023
  • First Sale Date:
    12/08/2023
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $700,000
  • Amount Remaining:
    $1,300,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Unsecured Convertible Promissory Note and Restricted Stock Grant for shares of Class A Common Stock.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Ceros Financial Services, Inc. 37869 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
OS Therapies Inc/s/Paul A. Romness, MPHPaul A. Romness, MPHPresident & Chief Executive Officer2023-12-14